Analysts' Actions -- AOL, Encana, Humana, Microsoft and More

NEW YORK (TheStreet) -- RATINGS CHANGES

AOL (AOL) was downgraded at Cantor Fitzgerald to sell from buy. Twelve-month price target is $47. Analysts are downgrading AOL on the back of AOL's acquisition by Verizon (VZ) for $50 a share in an all-cash transaction.

Denbury Resources (DNR) was downgraded to sell at TheStreet Ratings. You can view the full analysis from the report here: DNR Ratings Report.

Encana (ECA) was downgraded at RBC Capital to sector perform from outperform. Valuation call, based on a $15 price target.

Humana (HUM) was downgraded at Sterne Agee CRT to underperform. Twelve-month price target is $150. Company has potential earnings downside in the coming quarters, Sterne Agee CRT said.

Kimberly-Clark (KMB) was upgraded at Barclays to overweight from equal-weight. Twelve-month price target is $124. Organic sales growth should outperform the industry, Barclays said.

Magellan Health (MGLN) was upgraded at Jefferies to buy from hold. Twelve-month price target is $78. Since initiating two years ago, Jefferies has been patiently waiting for improved revenue visibility on MGLN's two growth initiatives and a better risk/reward profile, Jefferies said. The 14% pullback gives investors an attractive entry. Jefferies estimates Magellan Health shares are worth about $100 (60% upside) in two to three years if management executes.

Microsoft (MSFT) was upgraded at Deutsche Bank to buy from hold. Valuation call, based on a 12-month price target of $55, Deutsche Bank said.

Mobileye (MBLY) was initiated with a sector weight rating at Keybanc. No price target. Mobileye has a huge technology lead in active safety/autonomous driving, but the stock's valuation reflects what Keybanc believes are "optimistic" adoption scenarios for each with little discounting for future competitive risk, Keybanc said.

Nordic American Tanker (NAT) was upgraded to buy at TheStreet Ratings. You can view the full analysis from the report here: NAT Ratings Report.

Nabors (NBR) was downgraded at BMO Capital to market perform from outperform. Twelve-month price target is $18. Company has limited earnings upside potential, BMO Capital said.

Editor's note: To see analysts' stock comments and changes to price targets and earnings estimates, go to "Street Notes," which is available only to Real Money subscribers. To find out how to become a subscriber, please click here.

Follow TheStreet on Twitter and become a fan on Facebook.

This article was written by a staff member of TheStreet.

More from Stocks

Finding Stocks Right for You: Cramer's 'Mad Money' Recap (Friday 8/25/18)

Finding Stocks Right for You: Cramer's 'Mad Money' Recap (Friday 8/25/18)

Flashback Friday: Amazon, Chip Stocks, Memorial Day

Flashback Friday: Amazon, Chip Stocks, Memorial Day

Week Ahead: Wall Street Looks to Jobs Report as North Korea Meeting Less Certain

Week Ahead: Wall Street Looks to Jobs Report as North Korea Meeting Less Certain

Dow and S&P 500 Decline, Energy Shares Fall as U.S. Crude Oil Slides 4%

Dow and S&P 500 Decline, Energy Shares Fall as U.S. Crude Oil Slides 4%

Replay: Jim Cramer on the Markets, 10-Year Yield, Oil Prices and Foot Locker

Replay: Jim Cramer on the Markets, 10-Year Yield, Oil Prices and Foot Locker